Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial. - Rao MKP; Siddananjappa L; Sidana N; Deshmukh A; Diwari B; Podder I; Kumar S; Mittal R; Daultani P; Jaiswal A; Chinda M (Cureus, 2024)